Economic Evaluation of Prenatal and Postpartum Care in Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review.
Economic Evaluation of Prenatal and Postpartum Care in Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review.
复制标题
妊娠期糖尿病和妊娠期高血压疾病妇女产前和产后护理的经济学评价：一项系统评价。
DOI：
10.1016/j.jval.2022.07.014
复制
发表时间：
2022-12
期刊：
影响因子：
4.5
通讯作者：
Li, Yan
中科院分区：
文献类型：
--
作者：
Li, Weixin;Kim, Chi-Son;Howell, Elizabeth A.;Janevic, Teresa;Liu, Bian;Shi, Lizheng;Li, Yan
关键词：
总结有关妊娠糖尿病（GDM）和妊娠期高血压疾病（HDP）管理的产前和产后干预措施的经济结果的证据，评估每项研究的质量，并确定可能为未来研究提供信息的研究差距。检索时间为 2000 年 1 月 1 日至 2021 年 10 月 1 日，包括 PubMed/MEDLINE、Embase、Cochrane 图书馆和 Cochrane 对照试验中央注册库等电子数据库。选定的研究纳入叙述综合，提取的数据以叙述和表格形式呈现。每项研究的质量均使用综合卫生经济评估报告标准和卫生经济标准共识清单进行评估。在通过系统评价确定的 22 项研究中，有 19 项报告了干预措施的良好成本效益。对于 HDP 的产前管理，与亲自就诊相比，家庭血压监测在改善孕产妇和新生儿结局方面具有成本效益。对于产后护理，对有 GDM 或 HDP 病史的女性来说，定期筛查高血压或代谢综合征并随后进行治疗比不进行筛查更具成本效益。现有的经济评估研究表明，产前家庭血压监测和产后高血压或代谢综合征筛查具有成本效益。然而，当前经济评估方法的局限性可能会降低证据的质量并需要进一步调查。对患有妊娠期糖尿病和妊娠期高血压疾病的妇女的产前和产后干预措施的经济评估进行了系统回顾。
To summarize evidence on the economic outcomes of prenatal and postpartum interventions for the management of gestational diabetes (GDM) and hypertensive disorders of pregnancy (HDP), assess the quality of each study, and identify research gaps that may inform future research. Electronic databases including PubMed/MEDLINE, Embase, the Cochrane Library, and Cochrane Central Register of Controlled Trials were searched from January 1, 2000, to October 1, 2021. Selected studies were included in narrative synthesis and extracted data were presented in narrative and tabular forms. The quality of each study was assessed using the Consolidated Health Economic Evaluation Reporting Standards and Consensus on Health Economic Criteria list. Among the 22 studies identified through the systematic review, 19 reported favorable cost-effectiveness of the intervention. For prenatal management of HDP, home blood pressure monitoring was found to be cost-effective compared to in-person visits in improving maternal and neonatal outcomes. For postpartum care, regular screening for hypertension or metabolic syndrome followed by subsequent treatment was found to be cost-effective compared to no screening in women with a history of GDM or HDP. Existing economic evaluation studies showed that prenatal home blood pressure monitoring and postpartum screening for hypertension or metabolic syndrome were cost-effective. However, limitations in the approach of the current economic evaluations may dampen the quality of the evidence and warrant further investigation. A systematic review of economic evaluations of prenatal and postpartum interventions in women with gestational diabetes and hypertensive disorders of pregnancy was conducted.
登录
查看更多内容
影响因子：
2.9
作者：
Cairns AE;Pealing L;Duffy JMN;Roberts N;Tucker KL;Leeson P;MacKillop LH;McManus RJ
通讯作者：
McManus RJ
影响因子：
7.2
作者：
Harrison, MJ;Kushner, KE;Mitchell, BF
通讯作者：
Mitchell, BF
DOI：
10.1161/hypertensionaha.116.07466
发表时间：
2016-10
期刊：
Hypertension (Dallas, Tex. : 1979)
影响因子：
--
作者：
Ahmed RJ;Gafni A;Hutton EK;Hu ZJ;Pullenayegum E;von Dadelszen P;Rey E;Ross S;Asztalos E;Murphy KE;Menzies J;Sanchez JJ;Ganzevoort W;Helewa M;Lee SK;Lee T;Logan AG;Moutquin JM;Singer J;Thornton JG;Welch R;Magee LA
通讯作者：
Magee LA
影响因子：
--
作者：
Byford, S;Raftery, J
通讯作者：
Raftery, J
影响因子：
2
作者：
Drost, J. T.;Grutters, J. P. C.;Maas, A. H. E. M.
通讯作者：
Maas, A. H. E. M.